Hodgkin's lymphoma historical perspective
Jump to navigation
Jump to search
|
Hodgkin's lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hodgkin's lymphoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Hodgkin's lymphoma historical perspective |
|
Risk calculators and risk factors for Hodgkin's lymphoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]Mohsen Basiri M.D.
Overview
Hodgkin's lymphoma was first described by Thomas Hodgkin, a British physician, in 1832. Since then, tremendous efforts of many scientifics have been continuing to provide more precise and comprehensive with pathology, staging, and treatment of Hodgkin's lymphoma.
Historical Perspective
- Hodgkin's lymphoma was first described by Thomas Hodgkin, a British physician, in 1832.Although earliest description for this disease was provided by Marcello Malpighi in 1666.[1][2]
- Dr. Hodgkin's report of macroscopic description entitled "On some morbid appearances of the absorbent glands and spleen", was presented to the Medical and Chirurgical Society in London in 1832.[1] [3]
- In 1856, Samuel Wilks independently reported on a series of patients with the same disease that Hodgkin had previously described.[3] Wilks, a successor to Hodgkin at Guy's Hospital, was unaware of Hodgkin's prior work on the subject. Bright made Wilks aware of Hodgkin's contribution and in 1865, Wilks published a second paper, entitled "Cases of enlargement of the lymphatic glands and spleen", in which he called the disease "Hodgkin's disease" in honor of his predecessor.[3]
- Theodor Langhans and WS Greenfield first described the microscopic characteristics of Hodgkin's lymphoma in 1872 and 1878, respectively.[1]
- The cytogenetic characteristics of the malignant cells of Hodgkin's lymphoma which now is known as Reed–Sternberg cells, were described by Carl Sternberg, and Dorothy Reed in 1898 and 1902, respectively.[1][4]
- In 1944, Jackson and Parker classified Hodgkin’s lymphoma into three subtypes: early Hodgkin's disease or paragranuloma, granuloma, and sarcoma. In 1956, Smetana and Cohen proposed a histopathological variant for granulomatous Hodgkin's disease, with sclerotic changes and better prognosis. [5]
- In 1964 , Lukes, Butler, and Hicks termed this form as nodular sclerosis Hodgkin's disease. Their categorization system, simplified at the Rye conference in 1965 and has been used commonly from then on. [6]
- In 1993 the International Lymphoma Study Group (ILSG) in Berlin, provided a new lymphoma classification system and their consensus released as revised European–American lymphoma (REAL) classification In 1994, and subdivided Hodgkin’s lymphoma into two main types: lymphocyte predominant Hodgkin’s lymphoma and common Hodgkin’s lymphoma. [7]
- Since 1997 The World Health Organisation (WHO) has been starting a project with committees of international hematopathologists and oncologists, who have developed lists and definitions of disease entities to ensure that the classification will be helpful to clinicians. They proposed their first approach in 2000 and after that, the relevant Clinical Advisory Committee (CAC) updates its latest revision every few years. [8]
References
- ↑ 1.0 1.1 1.2 1.3 Hellman S (2007). "Brief Consideration of Thomas Hodgkin and His Times". In Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM. Hodgkin Lymphoma (2nd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. pp. 3–6. ISBN 0-7817-6422-X.
- ↑ Hodgkin T (1832). "On some morbid experiences of the absorbent glands and spleen". Med Chir Trans. 17: 69–97.
- ↑ 3.0 3.1 3.2 Geller SA (August 1984). "Comments on the anniversary of the description of Hodgkin's disease". Journal of the National Medical Association. 76 (8): 815–7. PMC 2609834. PMID 6381744.
- ↑ S. A. Pileri, S. Ascani, L. Leoncini, E. Sabattini, P. L. Zinzani, P. P. Piccaluga, A. Jr Pileri, M. Giunti, B. Falini, G. B. Bolis & H. Stein (2002). "Hodgkin's lymphoma: the pathologist's viewpoint". Journal of clinical pathology. 55 (3): 162–176. PMID 11896065. Unknown parameter
|month=ignored (help) - ↑ S. A. Pileri, S. Ascani, L. Leoncini, E. Sabattini, P. L. Zinzani, P. P. Piccaluga, A. Jr Pileri, M. Giunti, B. Falini, G. B. Bolis & H. Stein (2002). "Hodgkin's lymphoma: the pathologist's viewpoint". Journal of clinical pathology. 55 (3): 162–176. PMID 11896065. Unknown parameter
|month=ignored (help) - ↑ Z. Mechl & V. Kolar (1975). "[Chemotherapy of malignant melanoma]". Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti. 54 (6): 405–407. PMID 1145344. Unknown parameter
|month=ignored (help) - ↑ N. L. Harris, E. S. Jaffe, H. Stein, P. M. Banks, J. K. Chan, M. L. Cleary, G. Delsol, C. De Wolf-Peeters, B. Falini & K. C. Gatter (1994). "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group". Blood. 84 (5): 1361–1392. PMID 8068936. Unknown parameter
|month=ignored (help) - ↑ N. L. Harris, E. S. Jaffe, J. Diebold, G. Flandrin, H. K. Muller-Hermelink, J. Vardiman, T. A. Lister & C. D. Bloomfield (2000). "The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997". Histopathology. 36 (1): 69–86. PMID 10632755. Unknown parameter
|month=ignored (help)